These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 36321305)
1. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan. Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305 [TBL] [Abstract][Full Text] [Related]
2. [Data-Sharing Systems of the Center for Cancer Genomics and Advanced Therapeutics(C-CAT)Repository Database and Expectation for the Future Medical Research and Development]. Suzuki T Gan To Kagaku Ryoho; 2022 Nov; 49(11):1175-1182. PubMed ID: 36412016 [TBL] [Abstract][Full Text] [Related]
3. Establishment and implementation of Cancer Genomic Medicine in Japan. Mukai Y; Ueno H Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217 [TBL] [Abstract][Full Text] [Related]
4. Cancer genomic medicine in Japan. Mano H Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(7):316-321. PubMed ID: 32788553 [TBL] [Abstract][Full Text] [Related]
5. [Current Status and Future Direction of Cancer Genomic Medicine in Japan]. Muto M Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946 [TBL] [Abstract][Full Text] [Related]
6. Cancer genomic medicine in Japan and the roles of pharmacists. Aomori T; Sakurai H; Nishihara H Pharmacogenet Genomics; 2022 Aug; 32(6):242-245. PubMed ID: 35696282 [TBL] [Abstract][Full Text] [Related]
7. [Preparation of the Cancer Genomic Medicine in the Tohoku District-Activity of Tohoku University Hospital as the Cancer Genome Medicine Core Base Hospital in Japan]. Ishioka C Gan To Kagaku Ryoho; 2021 Jul; 48(7):878-881. PubMed ID: 34267020 [TBL] [Abstract][Full Text] [Related]
8. Patient survey on cancer genomic medicine in Japan under the national health insurance system. Kage H; Akiyama N; Chang H; Shinozaki-Ushiku A; Ka M; Kawata J; Muto M; Okuma Y; Okita N; Tsuchihara K; Kikuchi J; Shirota H; Hayashi H; Kokuryo T; Yachida S; Hirasawa A; Kubo M; Kenmotsu H; Tanabe M; Ushiku T; Muto K; Seto Y; Oda K Cancer Sci; 2024 Mar; 115(3):954-962. PubMed ID: 38273803 [TBL] [Abstract][Full Text] [Related]
9. [The Role of C-CAT, the Repository Database of Cancer Genomic Medicine in Japan]. Yoshida T Gan To Kagaku Ryoho; 2019 Apr; 46(4):630-634. PubMed ID: 31164498 [TBL] [Abstract][Full Text] [Related]
10. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan. Kanai M Curr Oncol; 2022 Sep; 29(10):7272-7284. PubMed ID: 36290850 [TBL] [Abstract][Full Text] [Related]
11. [Panel Discussion - Problems in the Cancer Genomic Medicine]. Ishioka C; Muto M; Yachida S; Shirota H; Hirasawa A; Miyagawa K; Ashizawa K; Kinoshita I; Nishihara H; Matsuura N; Sakurai A Gan To Kagaku Ryoho; 2022 Sep; 49(9):1014-1017. PubMed ID: 36156030 [TBL] [Abstract][Full Text] [Related]
12. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology]. Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018 [TBL] [Abstract][Full Text] [Related]
13. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan. Sunami K; Naito Y; Aimono E; Amano T; Ennishi D; Kage H; Kanai M; Komine K; Koyama T; Maeda T; Morita S; Sakai D; Kohsaka S; Tsuchihara K; Yoshino T Int J Clin Oncol; 2021 Mar; 26(3):443-449. PubMed ID: 33385275 [TBL] [Abstract][Full Text] [Related]
14. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan]. Sunami K Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495 [TBL] [Abstract][Full Text] [Related]
15. [Precision Medicine Provided by National Health Insurance]. Muto M; Kondo T; Matsubara J; Kanai M; Matsumoto S; Ashida K; Suga J; Mukai K Gan To Kagaku Ryoho; 2020 Aug; 47(8):1158-1163. PubMed ID: 32829347 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan. Kage H; Shinozaki-Ushiku A; Ishigaki K; Sato Y; Tanabe M; Tanaka S; Tanikawa M; Watanabe K; Kato S; Akagi K; Uchino K; Mitani K; Takahashi S; Miura Y; Ikeda S; Kojima Y; Watanabe K; Mochizuki H; Yamaguchi H; Kawazoe Y; Kashiwabara K; Kohsaka S; Tatsuno K; Ushiku T; Ohe K; Yatomi Y; Seto Y; Aburatani H; Mano H; Miyagawa K; Oda K Cancer Sci; 2023 Apr; 114(4):1710-1717. PubMed ID: 36601953 [TBL] [Abstract][Full Text] [Related]
17. [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan]. Nishida T Gan To Kagaku Ryoho; 2018 Sep; 45(9):1223-1227. PubMed ID: 30237359 [TBL] [Abstract][Full Text] [Related]
18. The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan. Yoshida T; Yatabe Y; Kato K; Ishii G; Hamada A; Mano H; Sunami K; Yamamoto N; Kohno T Cancer Biol Med; 2023 May; 21(1):29-44. PubMed ID: 37133223 [TBL] [Abstract][Full Text] [Related]
19. The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine. Hatanaka Y; Kuwata T; Morii E; Kanai Y; Ichikawa H; Kubo T; Hatanaka KC; Sakai K; Nishio K; Fujii S; Okamoto W; Yoshino T; Ochiai A; Oda Y Pathol Int; 2021 Nov; 71(11):725-740. PubMed ID: 34614280 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of psychological distress, quality of life, and satisfaction among patients and family members following comprehensive genomic profiling testing: Protocol of the Quality of life for Cancer genomics and Advanced Therapeutics (Q-CAT) study. Nishino M; Fujimori M; Koyama T; Hirata M; Tanabe N; Shimizu T; Yamamoto N; Uchitomi Y PLoS One; 2023; 18(5):e0283968. PubMed ID: 37235572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]